COMP <GO>
VCEL vs VIR // FREE CASH FLOW YIELD
Vericel Corporation (NASDAQ) VS. Vir Biotechnology Inc. (NASDAQ) • 15-METRIC TALLY: VCEL 8
— VIR 2
▲ FREE CASH FLOW YIELD LEADER: VCEL
LAST: $40.51 (+0.62%) • MKT CAP: $2.07B
fcf-yield
1.13%
LAST: $11.00 (-2.65%) • MKT CAP: $1.88B
fcf-yield
-19.74%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VCEL VS. VIR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | VCEL | VIR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 74.40% | 96.00% | -21.60 | VIR | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 3.40% | -35.00% | +38.40 | VCEL | /roic <GO> |
| EV/EBITDA & P/E Valuation | 61.4x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 1.13% | -19.74% | +20.87 | VCEL | /fcf-yield <GO> |
| Operating Margin | 4.00% | -60.00% | +64.00 | VCEL | /operating-margins <GO> |
| Net Profit Margin | 6.00% | -60.00% | +66.00 | VCEL | /net-margins <GO> |
| Revenue Growth (YoY) | 16.50% | -7.60% | +24.10 | VCEL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 9.94 | 2.40 | +7.54 | VCEL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 4/9 | +4.00 | VCEL | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.7 | 49.4 | -1.70 | VIR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 111.7x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.07B | $1.88B | $193.6M | VCEL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | VCEL REV | VIR REV | VCEL GROSS % | VIR GROSS % | VCEL FCF | VIR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $276.3M | $68.6M | 74.4% | 98.0% | $24.7M | -$396.6M |
| FY 2024 | $237.2M | $74.2M | 72.6% | 98.0% | -$5.8M | -$453.7M |
| FY 2023 | $197.5M | $86.2M | — | — | $35.3M | -$778.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VCEL // BETA —
VIR // BETA —